Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedOnly a backend revision update is shown, from v3.4.1 to v3.4.2, with no visible changes to the study page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision from v3.4.0 to v3.4.1 appears to be a version update with no visible changes to study content or structure on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision from v3.3.3 to v3.3.4; no substantive changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded a dedicated Locations section highlighting Illinois as a study site. Removed the separate Illinois Locations entry and the HHS Vulnerability Disclosure link in the prior revision.SummaryDifference0.2%

- Check98 days agoChange DetectedMinor backend version updates (from v3.2.0 to v3.3.2) with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.